S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02%
Next Bullish Trade
Sign in
AEON

AEON AEON

$0.29 +0.00 (-0.67%)
Deep pullback · -3.81σ Hot zone
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · AEON

Momentum reads · latest daily bar
Last
$0.29
+-0.00 (-0.67%)
Mkt cap
$13M
Healthcare
RSI(14)
19.7
oversold
Stochastic %K
7.8
oversold
MFI(14)
1.0
oversold
ADX(14)
53.3
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 — $-0.0B $-0.0B $-0.0B — —
2025-12-31 — $-0.0B $-0.0B $-0.0B — —
2025-09-30 — $-0.0B $-0.0B $-0.0B — —
2025-06-30 — $-0.0B $-0.0B $-0.0B — —
2025-03-31 — $0.0B $-0.0B $-0.0B — —
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare AEON vs peers

Line AEON up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing AEON no peers yet — add up to 4 below
Sector peers + LLY + UNH + JNJ + MRK + ABBV + PFE
Popular + AAPL + MSFT + NVDA + AMZN + GOOG + META + TSLA + AVGO
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Add tickers to compare with AEON

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

Earnings replay · last 9 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-05-14 -0.25 -0.44 +44.2% -9.9%
2026-03-30 -3.72 -0.20 -1714.6% -0.5%
2025-11-14 -0.39 -0.43 +9.3% -3.9%
2025-08-12 -0.60 -0.35 -71.4% +16.1%
2024-11-13 -11.52 -11.52 — -11.3%
2024-08-12 5.34 -13.68 +139.0% -1.0%
2024-05-14 -104.80 -22.32 -369.6% -3.1%
2024-03-29 -51.12 -28.80 -77.5% -36.0%
2023-11-13 82.80 -38.16 +317.0% +11.4%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
AEON ★ $0B — -0.4 — -0.2 -0.4 — — — -48.93%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0% —
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% — 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 10.78%

HolderShares% out
Dauntless Investment Group, LLC 2,527,775 9.61%
Vanguard Capital Management LLC 90,529 0.34%
Geode Capital Management, LLC 87,062 0.33%
Blue Owl Capital Holdings LP 42,353 0.16%
Formidable Asset Management, Llc 20,024 0.08%
Xtx Topco Ltd 20,424 0.08%
Vanguard Fiduciary Trust Co 14,702 0.06%
Jane Street Group, LLC 16,376 0.06%
LPL Financial LLC 11,507 0.04%
UBS Group AG 4,182 0.02%

Insider activity · 90d

5 buys / 0 sells · ratio 5.0 · Finnhub

  • Forth Marc BUY 973,231
  • Carter Eric G BUY 258,705
  • FISCHER JOST BUY 489,469
  • Thunen Shelley B BUY 258,705
  • PALMISANO ROBERT J BUY 258,705

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$5.0
Mean
$6.7
High
$8.4
Analysts
2
Recommendation distribution · period 2026-07-01
2
5
1
Revision trend (2026-04-01 → 2026-07-01): net 7 → 7 0 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
8-K 2026-07-15 8-K view ·
S-1 2026-07-08 S-1 view ·
4 2026-06-22 OWNERSHIP DOCUMENT view ·
4 2026-06-22 OWNERSHIP DOCUMENT view ·
4 2026-06-22 OWNERSHIP DOCUMENT view ·
4 2026-06-22 OWNERSHIP DOCUMENT view ·
4 2026-06-22 OWNERSHIP DOCUMENT view ·
8-K 2026-06-17 8-K view ·
8-K 2026-05-14 8-K view ·
10-Q 2026-05-14 10-Q view ·
8-K 2026-05-14 8-K view ·
DEF 14A 2026-04-29 DEF 14A view ·
4 2026-04-03 OWNERSHIP DOCUMENT view ·
8-K 2026-04-03 8-K view ·
10-K 2026-03-30 10-K view ·
8-K 2026-03-30 8-K view ·
4 2026-03-11 OWNERSHIP DOCUMENT view ·
8-K 2026-03-09 8-K view ·
4 2026-03-05 OWNERSHIP DOCUMENT view ·
4 2026-03-05 OWNERSHIP DOCUMENT view ·
4 2026-02-19 OWNERSHIP DOCUMENT view ·
8-K 2026-01-21 8-K view ·
8-K 2026-01-12 8-K view ·
DEF 14A 2025-12-29 DEF 14A view ·
8-K 2025-12-15 8-K view ·
8-K 2025-12-04 8-K view ·
10-Q 2025-11-14 10-Q view ·
8-K 2025-11-14 8-K view ·
8-K 2025-11-13 8-K view ·
8-K 2025-09-08 8-K view ·
10-Q 2025-08-12 10-Q view ·
8-K 2025-08-12 8-K view ·
8-K 2025-06-13 8-K view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-21 Insider transaction (Form 4) view ·
8-K 2025-05-20 8-K view ·
4 2025-05-16 Insider transaction (Form 4) view ·
10-Q 2025-05-14 10-Q view ·
8-K 2025-05-14 8-K view ·
4 2025-05-01 Insider transaction (Form 4) view ·
DEF 14A 2025-04-29 DEF 14A view ·
8-K 2025-04-25 8-K view ·
8-K 2025-04-21 8-K view ·
8-K 2025-04-08 8-K view ·
8-K 2025-03-27 8-K view ·
10-K 2025-03-24 10-K view ·
8-K 2025-03-24 8-K view ·
8-K 2025-03-10 8-K view ·
8-K 2025-02-24 8-K view ·
8-K 2025-02-07 8-K view ·
DEF 14A 2025-01-23 DEF 14A view ·
8-K 2025-01-07 FORM 8-K view ·

About AEON

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.

Options picks · AEON

ITM + OTM ideas from the latest scan

Loading…

Congress trades · AEON

STOCK Act disclosures

Loading…

SEC filings & insiders · AEON

EDGAR · live

Loading…

Holders · AEON

Institutions & insider activity

Loading…